These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1716382)

  • 1. Potentiation of BrCCl3 hepatotoxicity by chlordecone: biochemical and ultrastructural study.
    Faroon OM; Henry RW; Soni MG; Mehendale HM
    Toxicol Appl Pharmacol; 1991 Sep; 110(2):185-97. PubMed ID: 1716382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromotrichloromethane hepatotoxicity. The role of stimulated hepatocellular regeneration in recovery: biochemical and histopathological studies in control and chlordecone pretreated male rats.
    Faroon OM; Mehendale HM
    Toxicol Pathol; 1990; 18(4 Pt 2):667-77. PubMed ID: 1709515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of bromotrichloromethane hepatotoxicity and lethality by chlordecone preexposure in the rat.
    Agarwal AK; Mehendale HM
    Fundam Appl Toxicol; 1982; 2(4):161-7. PubMed ID: 6193023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perturbations in polyamines and related enzymes following chlordecone-potentiated bromotrichloromethane hepatotoxicity.
    Rao SB; Young RA; Mehendale HM
    J Biochem Toxicol; 1990; 5(1):23-32. PubMed ID: 1698228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PB-PK derived metabolic constants, hepatotoxicity, and lethality of BrCCl3 in rats pretreated with chlordecone, phenobarbital, or mirex.
    Thakore KN; Gargas ML; Andersen ME; Mehendale HM
    Toxicol Appl Pharmacol; 1991 Jul; 109(3):514-28. PubMed ID: 1712992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection from chlordecone-amplified carbon tetrachloride toxicity by cyanidanol: biochemical and histological studies.
    Soni MG; Mehendale HM
    Toxicol Appl Pharmacol; 1991 Mar; 108(1):46-57. PubMed ID: 1706539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered hepatic energy status in chlordecone (Kepone)-potentiated CCl4 hepatotoxicity.
    Kodavanti PR; Kodavanti UP; Mehendale HM
    Biochem Pharmacol; 1990 Aug; 40(4):859-66. PubMed ID: 1696822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pivotal role of hepatocellular regeneration in the ultimate hepatotoxicity of CCl4 in chlordecone-, mirex-, or phenobarbital-pretreated rats.
    Kodavanti PR; Kodavanti UP; Faroon OM; Mehendale HM
    Toxicol Pathol; 1992; 20(4):556-69. PubMed ID: 1284994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatotoxicity and lethality of halomethanes in Mongolian gerbils pretreated with chlordecone, phenobarbital or mirex.
    Cai Z; Mehendale HM
    Arch Toxicol; 1991; 65(3):204-12. PubMed ID: 1711308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection from chlordecone-amplified carbon tetrachloride toxicity by cyanidanol: regeneration studies.
    Soni MG; Mehendale HM
    Toxicol Appl Pharmacol; 1991 Mar; 108(1):58-66. PubMed ID: 1706540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of calcium homeostasis leads to progressive phase of chlordecone-potentiated carbon tetrachloride hepatotoxicity.
    Kodavanti PR; Rao VC; Mehendale HM
    Toxicol Appl Pharmacol; 1993 Sep; 122(1):77-87. PubMed ID: 7690997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplified interactive toxicity of chemicals at nontoxic levels: mechanistic considerations and implications to public health.
    Mehendale HM
    Environ Health Perspect; 1994 Nov; 102 Suppl 9(Suppl 9):139-49. PubMed ID: 7535226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of halomethane hepatotoxicity by chlordecone: a hypothesis for the mechanism.
    Mehendale HM
    Med Hypotheses; 1990 Dec; 33(4):289-99. PubMed ID: 1708849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of halomethane hepatotoxicity: chlordecone and carbon tetrachloride.
    Mehendale HM
    Fundam Appl Toxicol; 1984 Jun; 4(3 Pt 1):295-308. PubMed ID: 6204898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine triphosphate protection of chlordecone-amplified CCl4 hepatotoxicity and lethality.
    Soni MG; Mehendale HM
    J Hepatol; 1994 Feb; 20(2):267-74. PubMed ID: 7516359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of the lethal interaction of chlordecone and CCl4 at non-toxic doses.
    Mehendale HM
    Toxicol Lett; 1989 Dec; 49(2-3):215-41. PubMed ID: 2481348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of chlordecone-potentiated carbon tetrachloride hepatotoxicity and lethality by partial hepatectomy.
    Bell AN; Young RA; Lockard VG; Mehendale HM
    Arch Toxicol; 1988 Apr; 61(5):392-405. PubMed ID: 2456051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related susceptibility to chlordecone-potentiated carbon tetrachloride hepatotoxicity and lethality is due to hepatic quiescence.
    Dalu A; Warbritton A; Bucci TJ; Mehendale HM
    Pediatr Res; 1995 Aug; 38(2):140-8. PubMed ID: 7478807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlordecone-induced potentiation of carbon tetrachloride hepatotoxicity: a light and electron microscopic study.
    Lockard VG; Mehendale HM; O'Neal RM
    Exp Mol Pathol; 1983 Oct; 39(2):230-45. PubMed ID: 6194012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of hepatocellular regeneration in chlordecone potentiated hepatotoxicity of carbon tetrachloride.
    Kodavanti PR; Joshi UM; Young RA; Bell AN; Mehendale HM
    Arch Toxicol; 1989; 63(5):367-75. PubMed ID: 2479360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.